Wei Lue Tong, MD

Cancer Focus:
Colorectal Cancer, Kidney (Renal Cell) Cancer, Liver (Hepatocellular) Cancer, Lung Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Sarcoma, Thyroid Nodule/Mass

Dr. Tong received his MD degree from the University of South Florida, Tampa. He completed an Interventional Radiology-Integrated Residency, serving as Chief Resident at the Cleveland Clinic, Ohio.

Dr. Tong’s clinical interests include interventional oncology, particularly transcatheter and percutaneous treatment of liver and renal tumors, liver venous deprivation, portal hypertension, lymphatic interventions, and prostate artery embolization 

His research interests include the refinement of techniques for loco-regional therapies.

• Shah A, Tong WL, Mina D, Yeisley C, Beer-Furlan A, Al-Roubaie M. Emergency endovascular management of oropharyngeal tumor hemorrhage via aberrant vertebral collateral pathways: illustrative case. J Neurosurg Case Lessons. 2026 Sep.12(10). Pubmedid: 42704912.
• Jain R, Dallas A, Xu H, Shwaiki O, Salloum E, Tong WL. Ectopic adrenal cortical adenoma arising within the kidney in the setting of adrenal-renal fusion: Two cases mimicking renal cell carcinoma and the role of biopsy and ablation. Radiol Case Rep. 2026 Nov.21(11):5306-5313. Pubmedid: 42622011. Pmcid: PMC13488045.
• Mina D, Gustainyte V, Venkat S, Tong WL, Kocharyan H. Percutaneous Cryoablation of Elastofibroma Dorsi in a 73-Year-Old Woman: A Novel Minimally Invasive Alternative. Cureus. 2025 Dec.17(12):e99296. Pubmedid: 41542006. Pmcid: PMC12803006.
• Tong WL, Gadani S. Chronic Portal Vein Thrombosis: Diagnosis, Management, and Review of the Literature. Tech Vasc Interv Radiol. 2025 Dec.28(4):101084. Pubmedid: 41242836.
• Sharma M, Tong WL, Thompson D, Vachharajani TJ. Placing an appropriate tunneled dialysis catheter in an appropriate patient including the nonconventional sites. Cardiovasc Diagn Ther. 2023 Feb.13(1):281-290. Pubmedid: 36864971. Pmcid: PMC9971288.
• Angelakakis G, Serraneau KS, Barker VR, Callahan BM, Tong WL, Zaman S, Huda TI, Blanck G. TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparities. Int J Immunogenet. 2023 Apr.50(2):41-47. Pubmedid: 36585798.
• Zaman S, Chobrutskiy BI, Patel JS, Diviney A, Tu YN, Tong WL, Gill T, Blanck G. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis. Viral Immunol. 2020 Jun.33(5):404-412. Pubmedid: 32315578.
• Tu YN, Tong WL, Callahan BM, Chobrutskiy BI, Blanck G. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate. Anticancer Res. 2020 Apr.40(4):2043-2051. Pubmedid: 32234895.
• Dutil J, Teer JK, Golubeva V, Yoder S, Tong WL, Arroyo N, Karam R, Echenique M, Matta JL, Monteiro AN. Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico. Sci Rep. 2019 Nov.9(1):17769. Pubmedid: 31780696. Pmcid: PMC6882826.
• Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Mihyu MM, Blanck G. MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration. Clin Biochem. 2019 Jan.63:85-91. Pubmedid: 30414845.
• Tong WL, Callahan BM, Tu YN, Zaman S, Chobrutskiy BI, Blanck G. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast Cancer Res Treat. 2019 Jan.173(1):167-177. Pubmedid: 30229447.
• Clark KR, Tong WL, Callahan BM, Yavorski JM, Tu YN, Blanck G. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates. Int J Immunogenet. 2019 Feb.46(1):31-37. Pubmedid: 30474304.
• Pakasticali N, Gill T, Chobrutskiy BI, Tong WL, Ramsamooj M, Blanck G. TRAV gene segments further away from the TRAJ gene segment cluster appear more commonly in human tumor and blood samples. Mol Immunol. 2019 Dec.116:174-179. Pubmedid: 31704500.
• Callahan BM, Yavorski JM, Tu YN, Tong WL, Kinskey JC, Clark KR, Fawcett TJ, Blanck G. T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer Immunol Immun. 2018 Jun.67(6):885-892. Pubmedid: 29508024. Pmcid: PMC11028132.
• Kinskey JC, Tu YN, Tong WL, Yavorski JM, Blanck G. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival. Cancer Microenviron. 2018 Jun.11(1):51-59. Pubmedid: 29404962. Pmcid: PMC6008263.
• Tu YN, Tong WL, Yavorski JM, Blanck G. Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations. Cancer Microenviron. 2018 Jun.11(1):41-49. Pubmedid: 29357011. Pmcid: PMC6008264.
• Mai AT, Tong WL, Tu YN, Blanck G. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers. Int Immunol. 2018 Feb.30(1):35-40. Pubmedid: 29361059. Pmcid: PMC7958811.
• Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol. 2018 Dec.140(3):697-704. Pubmedid: 30382482.
• Callahan BM, Tong WL, Blanck G. T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunol Res. 2018 Apr.66(2):219-223. Pubmedid: 29594966.
• Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Blanck G. Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme. Biochem Bioph Res Co. 2018 09.503(4):2218-2225. Pubmedid: 29953855.
• Tong WL, Tu YN, Samy MD, Sexton WJ, Blanck G. Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother. 2017 Mar.13(3):501-506. Pubmedid: 28085544. Pmcid: PMC5360147.
• Samy MD, Tong WL, Yavorski JM, Sexton WJ, Blanck G. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer. Cancer Immunol Immun. 2017 Mar.66(3):403-410. Pubmedid: 27995306. Pmcid: PMC11028825.
• Tu YN, Tong WL, Samy MD, Yavorski JM, Kim M, Blanck G. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression. Int J Cancer. 2017 Jun.140(11):2568-2576. Pubmedid: 28256716.
• Tu YN, Tong WL, Fawcett TJ, Blanck G. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens. Lab Invest. 2017 Dec.97(12):1516-1520. Pubmedid: 28805806.